Iron-Refractory Iron Deficiency Anemia: Clinical Trials

2 trials for Iron-Refractory Iron Deficiency Anemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Terminated 1

Follow Iron-Refractory Iron Deficiency Anemia: new trials by email Literature Review of Iron-Refractory Iron Deficiency Anemia trials Research Report on Iron-Refractory Iron Deficiency Anemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol
Fer-In-Sol, Shohl's solution, Triferic - Iron-Refractory Iron-Deficiency Anemia
Phase 2TerminatedRockwell Medical Technologies, Inc.12017-01-172020-09-22
Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers
Triferic, Fer-In-Sol, Shohl's solution - Iron-refractory, Iron-deficiency Anemia (IRIDA)
Phase 1CompletedRockwell Medical Technologies, Inc.142016-04-012019-02-01

Interventions

Citrates (2)  ·  ferric pyrophosphate (2)  ·  ferrous sulfate (2)  ·  spleen fibrinolytic proteinase (human) (2)  ·  Citric Acid (1)

Sponsors

Rockwell Medical Technologies, Inc. (2)

Countries

United States (1)

Top investigators

Raymond D Pratt, MD, FACP (2)